Diagnosis and treatment of orthostatic hypotension.
Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, Thijs RD.
Lancet Neurol. 2022 Aug;21(8):735-746. doi: 10.1016/S1474-4422(22)00169-7.
Management of Orthostatic Hypotension in Parkinson's Disease.
Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK.
J Parkinsons Dis. 2020;10(s1):S57-S64. doi: 10.3233/JPD-202036.
Treating Lows: Management of Orthostatic Hypotension.
Kulkarni S, Jenkins D, Dhar A, Mir F.
J Cardiovasc Pharmacol. 2024 Sep 1;84(3):303-315. doi: 10.1097/FJC.0000000000001597.
Orthostatic Hypotension in the Hypertensive Patient.
Biaggioni I.
Am J Hypertens. 2018 Nov 13;31(12):1255-1259. doi: 10.1093/ajh/hpy089.
[Hypotension].
Moriguchi A, Ogihara T.
Ryoikibetsu Shokogun Shirizu. 1996;(12):122-5.
[Orthostatic hypotension and supine hypertension: a practical guide to diagnosis and management].
Pensato U, Strocchi E, Cortelli P, Borghi C.
G Ital Cardiol (Rome). 2021 Jan;22(1):42-52. doi: 10.1714/3502.34882.
Impact of drugs on intradialytic hypotension: Antihypertensives and vasoconstrictors.
Chang TI.
Semin Dial. 2017 Nov;30(6):532-536. doi: 10.1111/sdi.12633. Epub 2017 Jul 5.
Timing of blood pressure medications and intradialytic hypotension.
Wang KM, Sirich TL, Chang TI.
Semin Dial. 2019 May;32(3):201-204. doi: 10.1111/sdi.12777. Epub 2019 Mar 5.
Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.
Baker J, Kimpinski K.
CNS Drugs. 2017 Aug;31(8):653-663. doi: 10.1007/s40263-017-0453-9.
[Orthostatic hypotension: marker of severity and management of antihypertensive treatment].
Fenech G, Safar M, Blacher J.
Presse Med. 2012 Nov;41(11):1116-21. doi: 10.1016/j.lpm.2012.02.008. Epub 2012 Apr 4.
